Farnesylated proteins and cell cycle progression
- 1 January 2001
- journal article
- review article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 84 (S37) , 64-70
Abstract
Post‐translational modification of proteins by the addition of a farnesyl group is critical for the function of a number of proteins involved in signal transduction. Farnesylation facilitates their membrane association and also promotes protein–protein interaction. Recently, progress has been made in understanding the biological significance of farnesylation. First, effects of farnesyltransferase inhibitors (FTIs) on cancer cells have been examined using a variety of human cancer cells. This study showed that one of the major effects of FTIs is to alter cell cycle progression. Both G0/G1 enrichment and G2/M accumulation were observed depending on the cell line examined. Second, a number of novel farnesylated proteins have been characterized. Of these, Rheb and CENP‐E,F are of particular interest. Rheb, a novel member of the Ras superfamily G‐proteins, may play a role in the G1 phase of the cell cycle. CENP‐E,F are centromere associated motors that play critical roles in mitosis. These results suggest important contributions of farnesylated proteins in the regulation of cell cycle progression. J. Cell. Biochem. Suppl. 37: 64–70, 2001.Keywords
This publication has 27 references indexed in Scilit:
- Protein farnesylation in mammalian cells: effects of farnesyltransferase inhibitors on cancer cellsCellular and Molecular Life Sciences, 2001
- Farnesyl Transferase Inhibitors Block the Farnesylation of CENP-E and CENP-F and Alter the Association of CENP-E with the MicrotubulesJournal of Biological Chemistry, 2000
- Cdk inhibitors, roscovitine and olomoucine, synergize with farnesyltransferase inhibitor (FTI) to induce efficient apoptosis of human cancer cell linesOncogene, 2000
- The Saccharomyces cerevisiae Rheb G-protein Is Involved in Regulating Canavanine Resistance and Arginine UptakeJournal of Biological Chemistry, 2000
- Growth inhibition of astrocytoma cells by farnesyl transferase inhibitors is mediated by a combination of anti-proliferative, pro-apoptotic and anti-angiogenic effectsOncogene, 1999
- Non-Ras targets of farnesyltransferase inhibitors: focus on RhoOncogene, 1998
- THE POTENTIAL OF FARNESYLTRANSFERASE INHIBITORS AS CANCER CHEMOTHERAPEUTICSAnnual Review of Pharmacology and Toxicology, 1997
- PROTEIN PRENYLATION: Molecular Mechanisms and Functional ConsequencesAnnual Review of Biochemistry, 1996
- A novel approach for expression cloning of small GTPases: identification, tissue distribution and chromosome mapping of the human homolog of rhebFEBS Letters, 1995
- Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in ras transgenic miceNature Medicine, 1995